- Home
- SMTI vs CVRX Comparison
SMTI vs CVRX Comparison
Compare SMTI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- CVRX
- Stock Information
- Founded
- SMTI 1982
- CVRX 2000
- Country
- SMTI United States
- CVRX United States
- Employees
- SMTI 141
- CVRX N/A
- Industry
- SMTI Medical/Dental Instruments
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SMTI Health Care
- CVRX Health Care
- Exchange
- SMTI Nasdaq
- CVRX Nasdaq
- Market Cap
- SMTI 251.6M
- CVRX 203.9M
- IPO Year
- SMTI N/A
- CVRX 2021
- Fundamental
- Price
- SMTI $29.25
- CVRX $10.09
- Analyst Decision
- SMTI Strong Buy
- CVRX Buy
- Analyst Count
- SMTI 2
- CVRX 7
- Target Price
- SMTI $50.00
- CVRX $14.00
- AVG Volume (30 Days)
- SMTI 22.8K
- CVRX 197.4K
- Earning Date
- SMTI 11-12-2025
- CVRX 11-04-2025
- Dividend Yield
- SMTI N/A
- CVRX N/A
- EPS Growth
- SMTI N/A
- CVRX N/A
- EPS
- SMTI N/A
- CVRX N/A
- Revenue
- SMTI $97,241,894.00
- CVRX $54,652,000.00
- Revenue This Year
- SMTI $24.49
- CVRX $11.32
- Revenue Next Year
- SMTI $14.43
- CVRX $18.58
- P/E Ratio
- SMTI N/A
- CVRX N/A
- Revenue Growth
- SMTI 34.29
- CVRX 23.11
- 52 Week Low
- SMTI $23.53
- CVRX $4.30
- 52 Week High
- SMTI $39.08
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- SMTI 44.28
- CVRX 75.47
- Support Level
- SMTI $28.00
- CVRX $8.50
- Resistance Level
- SMTI $30.99
- CVRX $10.49
- Average True Range (ATR)
- SMTI 1.35
- CVRX 0.57
- MACD
- SMTI -0.29
- CVRX 0.14
- Stochastic Oscillator
- SMTI 24.86
- CVRX 87.73
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.